Cargando…
Policy options for deploying anti-malarial drugs in endemic countries: a population genetics approach
BACKGROUND: Anti-malarial drugs are constantly exposed to the threat of evolving drug resistance so good stewardship of existing therapy is an essential component of public health policy. However, the widespread availability of numerous different drugs through informal providers could undermine offi...
Autores principales: | Antao, Tiago, Hastings, Ian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546853/ https://www.ncbi.nlm.nih.gov/pubmed/23244624 http://dx.doi.org/10.1186/1475-2875-11-422 |
Ejemplares similares
-
Spread of anti-malarial drug resistance: Mathematical model with implications for ACT drug policies
por: Pongtavornpinyo, Wirichada, et al.
Publicado: (2008) -
Measuring windows of selection for anti-malarial drug treatments
por: Kay, Katherine, et al.
Publicado: (2015) -
Optimizing the programmatic deployment of the anti-malarials artemether-lumefantrine and dihydroartemisinin-piperaquine using pharmacological modelling
por: Hodel, Eva Maria, et al.
Publicado: (2014) -
Anti-malarial drugs and the prevention of malaria in the population of malaria endemic areas
por: Greenwood, Brian
Publicado: (2010) -
Donor support for quality assurance and pharmacovigilance of anti-malarials in malaria-endemic countries
por: Kovacs, Stephanie D., et al.
Publicado: (2017)